Good Pharmacovigilance Practices (GVP): Legal Framework of the Global Pharmacovigilance Program
Description:
This course will help you understand the fundamental components of the many global pharmacovigilance guidelines, regulations, and reporting programs, with a special emphasis on European Union (or E.U.) Good Pharmacovigilance Practices (or G.V.P.) Guidelines and U.S. Food and Drug Administration (or U.S. F.D.A.) guidance.
Pharmacovigilance contributes to the protection of patients and public health in an essential way. For this reason, it is highly important for pharmaceutical manufacturers to follow Good Pharmacovigilance Practices with programs in place that focus on risk assessment and management.
Curriculum for this course:
Course Introduction
Course Overview | 32 secs |
What You'll Learn | 25 secs |
Legal Framework: Global Pharmacovigilance Program
European Union | 1 min 11 secs |
GVP and the EU Pharmacovigilance System | 33 secs |
Key Elements of The EU Pharmacovigilance System | 10 secs |
GVP Guidelines & Guidance Documents | 1 min 16 secs |
Modules Covering Major Pharmacovigilance Processes | 26 secs |
Product-Or-Population-Specific Considerations | 10 secs |
Risk Management and Pharmacovigilance | 16 secs |
The Risk Management Plan | 58 secs |
EU GVP Quick Knowledge Check | 30 secs |
Terms Related to Pharmacovigilance in the EU | 8 min |
R+EU Pharmacovigilance Terms Quick Knowledge Check | 30 secs |
United States | 1 min 27 secs |
US Pre-Marketing Risk Management | 1 min 1 secs |
US Post-Marketing Pharmacovigilance Assessments | 21 secs |
Risk Management Plan | 1 min |
Health Canada | 48 secs |
WHO | 53 secs |
ICH | 31 secs |
CIOMS | 48 secs |
CDSCO | 41 secs |
Conclusion
What We Covered | 46 secs |
Test Your Knowledge
Results
Revision History
Minor update: Assessment question bank reduced to improve learner experience. Assessment updated to fix reporting functionality. | V1.1 |
Talk to us
Find out how we can help you bring your life science training to the next level.